Introduced in 2005, the Russell Fundamental Indexes®, now called the Russell RAFI™ Index Series, provide an alternative weighting methodology that is not tied to market prices. Instead, weightings in this index series are derived using a blend of adjusted sales, retained operating cash flow and dividends plus buybacks, all averaged over five years. As we can see below, this approach to indexing has led to a difference in performance from the corresponding market-cap weighted benchmarks year-to-date.
To understand the drivers of this difference in performance we need to consider the main differences in construction of these two types of index. A key element within the construction of the Russell RAFI Index Series is that stock weights do not correspond to price movements. This means that the index weights tend to lean in the opposite direction from active trading—creating an implicit “contrarian” position.
The case typically put forward for contrarian weighting is two-fold. First there is the assertion that there is a tendency for stock prices to revert to their mean or intrinsic value. Market value, after all, is not purely random but tends to gravitate toward an unobserved central tendency. Fundamental indexes give us a way to get closer to that gravitational center, the intrinsic value, by using purely economic measures of a company’s size and success. Second, market participants mayto over-react to news about a stock—leading to the herding behavior we mentioned earlier. In a cap weighted index, these two factors lead to performance drag. That is, as a stock price rises above its intrinsic value, its weighting within the index rises in tandem. Then as the price reverts back to its mean, the performance of the index is dragged down by the falling price of a now overweight stock. The opposite is true for a stock price that falls below its intrinsic value. We can, for example, see this dynamic play out within the Health Care sector of the Russell 1000® Index in 2016.
As we find in the chart below, the Russell 1000 Health Care sector had returns of 15.0% from March through July of 2016. This substantial rise in the sector caused the sector’s weighting in the cap-weighted Russell 1000 to rise from 13.5% to 14.5% over the same period. Then in the period from August through October 2016, Health Care tumbled from its peak by -9.7%. This price drop coupled with the inflated weight for the sector magnified the impact on the cap-weighted index.
Conversely, the weighting of the Health Care sector within the corresponding Russell RAFI index has remained relatively constant in 2016 at around 10%. We can see in the attribution analysis below, that Health Care was a meaningful contributor to performance for the Fundamental Index, accounting for 0.98% of the 1.82% of its excess return over the Russell 1000.
In sum, stocks or sectors that have a strong trend in one direction and then a sharp reversal can result in a performance drag that can adversely affect the performance of cap-weighted indexes. The steadier weighting methodology in a fundamentally weighted index such as the Russell RAFI Index Series means that the performance drag can be minimized. So, this holiday season you might want to consider countering the herd mentality and evaluate a contrarian approach.
To read more on how different weighting techniques can affect index performance, see the FTSE Russell Blog.
 Name change as of December 1, 2016.
 http://www.ftse.com/products/downloads/Russell_RAFI_Index_Series_Construction_and_Methodology.pdf?894. Also,Goodwin, T. 2012. “The Russell Fundamental Index Series,” Russell Research.
© 2016 London Stock Exchange Group plc and its applicable group undertakings (the “LSE Group”). The LSE Group includes (1) FTSE International Limited (“FTSE”), (2) Frank Russell Company (“Russell”), (3) FTSE TMX Global Debt Capital Markets Inc. and FTSE TMX Global Debt Capital Markets Limited (together, “FTSE TMX”) and (4) MTSNext Limited (“MTSNext”). All rights reserved.
FTSE Russell® is a trading name of FTSE, Russell, FTSE TMX and MTS Next Limited. “FTSE®”, “Russell®”, “FTSE Russell®” “MTS®”, “FTSE TMX®”, “FTSE4Good®” and “ICB®” and all other trademarks and service marks used herein (whether registered or unregistered) are trade marks and/or service marks owned or licensed by the applicable member of the LSE Group or their respective licensors and are owned, or used under licence, by FTSE, Russell, MTSNext, or FTSE TMX.
All information is provided for information purposes only. Every effort is made to ensure that all information given in this publication is accurate, but no responsibility or liability can be accepted by any member of the LSE Group nor their respective directors, officers, employees, partners or licensors for any errors or for any loss from use of this publication or any of the information or data contained herein.
No member of the LSE Group nor their respective directors, officers, employees, partners or licensors make any claim, prediction, warranty or representation whatsoever, expressly or impliedly, either as to the results to be obtained from the use of the FTSE Russell indexes or the fitness or suitability of the indexes for any particular purpose to which they might be put.
No member of the LSE Group nor their respective directors, officers, employees, partners or licensors provide investment advice and nothing in this communication should be taken as constituting financial or investment advice. No member of the LSE Group nor their respective directors, officers, employees, partners or licensors make any representation regarding the advisability of investing in any asset. A decision to invest in any such asset should not be made in reliance on any information herein. Indexes cannot be invested in directly. Inclusion of an asset in an index is not a recommendation to buy, sell or hold that asset. The general information contained in this publication should not be acted upon without obtaining specific legal, tax, and investment advice from a licensed professional.
No part of this information may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior written permission of the applicable member of the LSE Group. Use and distribution of the LSE Group index data and the use of their data to create financial products require a license from FTSE, Russell, FTSE TMX, MTSNext and/or their respective licensors.
Past performance is no guarantee of future results. Charts and graphs are provided for illustrative purposes only. Index returns shown may not represent the results of the actual trading of investable assets. Certain returns shown may reflect back-tested performance. All performance presented prior to the index inception date is back-tested performance. Back-tested performance is not actual performance, but is hypothetical. The back-test calculations are based on the same methodology that was in effect when the index was officially launched. However, back- tested data may reflect the application of the index methodology with the benefit of hindsight, and the historic calculations of an index may change from month to month based on revisions to the underlying economic data used in the calculation of the index.